GUIFFRE CHRISTOPHERD T 4
4 · Pear Therapeutics, Inc. · Filed Jan 18, 2023
Insider Transaction Report
Form 4
GUIFFRE CHRISTOPHERD T
CFO, COO, Treas., & Asst. Sec.
Transactions
- Exercise/Conversion
Common Stock
2023-01-14+49,500→ 49,500 total - Exercise/Conversion
Restricted Stock Units
2023-01-14−49,500→ 100,500 total→ Common Stock (49,500 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of PEAR common stock.
- [F2]The remaining restricted stock units shall vest and settle as to 33% of the shares on January 14, 2024 and 34% on January 14, 2025.